Androgens and osteocalcin during the menstrual cycle

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 971-974

  Massafra, Cosimo ^a,c   De Felice, Claudio ^a   Agnusdei, Donato Pompeo ^b   Gioia, Dino ^a   Bagnoli, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CALCITONIN; CALCIUM; ESTRADIOL; OSTEOCALCIN; PARATHYROID HORMONE; PROGESTERONE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BONE MINERAL; BONE MINERALIZATION; CLINICAL ARTICLE; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM;

EID: 0033027646     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.3.971     Document Type: Article

References (26)

1. Baran DT, Whyte MP, Haussler MR, Deftos LJ, Slatopolsky E, Avioli L. 1980 Effect of the menstrual cycle on calcium-regulating hormones in the normal young woman. J Clin Endocrinol Metab. 50:377-379.
2. Buchanan JR, Santen RJ, Cavaliere A, Cauffman SW, Greer RB, Demers LM. 1986 Interaction between parathyroid hormone and endogenous estrogen in normal women. Metabolism. 35:489-494.
3. Muse KN, Manolagas SC, Deftos LJ, Alexander N, Yen SSC. 1986 Calcium-regulating hormones across the menstrual cycle. J Clin Endocrinol Metab. 62:1313-1316.
4. Nielsen HK, Brixen K, Bouillon R, Mosekilde L. 1990 Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab. 70:1431-1437.
5. Lopez-Moreno JM, Gonzales VG, Campino JC, Salvatierra AM, Croxatto HB. 1992 Serum osteocalcin in normal menstrual cycle. Medicina (B Aires). 52:37-40.
6. Pitkin RM, Reynolds WA, Williams GA, Hargis GK. 1978 Calcium-regulating hormones during the menstrual cycle. J Clin Endocrinol Metab. 47:626-632.
7. 3 during the menstrual cycle. Am J Obstet Gynecol. 144:880-884.
8. Tjellesen L, Christiansen C, Hummer L, Larse NE. 1983 Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle. Acta Endocrinol (Copenh). 102:476-480.
9. Colvard DS, Eriksen EF, Keeting PE, et al. 1989 Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 86:854-857.
10. Eriksen EF, Colvard DS, Berg NJ, et al. 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:84-86.
11. Kasperk CH, Wergedal JE, Farley JR, Linkart TA, Turner RT, Baylink DJ. 1989 Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 124:1576-1578.
12. Simberg N, Tiitinen A, Silfvast A, Viinikka L, Ylikorkala O. 1996 High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement. J Clin Endocrinol Metab. 80:646-651.
13. Slemenda C, Hui SL, Longcope C, Johnston CC. 1987 Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest. 80:1261-1269.
14. Davis SR, Burger HG. 1997 Use of androgens in postmenopausal women. Current Opin Obstet Gynecol. 9:177-180.
15. Davis SR, McCloud P, Strauss BJG, Burger H. 1995 Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:227-236.
16. Raisz LG, Wiita B, Artis A, et al. 1996 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 81:37-46.
17. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. 1995 Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol. 85:529-37.
18. Box GEP, Jenkins GM. 1976 Time series analysis: forecasting and control. Revised ed. Oakland, CA: Holden-Day Inc.
19. Johansen JS, Giwercman A, Hartwell D, et al. 1988 Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor 1, and serum testosterone. J Clin Endocrinol Metab. 67:273-278.
20. Delmas PD, Chatelain P, Malaval L, Bonne G. 1986 Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res. 1:333-338.
21. Slemenda CW, Longcope C, Peacock M, Hui S, Johnston CC. 1996 Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest. 97:14-21.
22. Buchanan JR, Hodspodar P, Myers C, Leuenberger P, Demers LM. 1988 Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab. 67:937-943.
23. Steinberg KK, Freni-Titulaer LW, DePuey EG, et al. 1989 Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 69:533-539.
24. Wild RA, Buchanan JR, Myers C, Demers LM. 1987 Declining adrenal androgens: an association with bone loss in ageing women. Proc Soc Exp Biol Med. 186:355-360.
25. Marshall DH, Crilly RG, Nordin BEC. 1977 Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women. Br Med J. 2:1177-1179.
26. Kleerekoper M. 1996 Biochemical markers of bone remodeling. Am J Med Sci. 312:270-277.